Disclosed herein are acridine compounds of formula Ia, wherein X is selected from NRA and C=ORA, and Y is O, S, NORA or NRA, and the other substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof in preventing, treating or ameliorating cancer or tumor metastasis in a mammal.